Vertex Pharmaceuticals is having a moment. Several moments, in fact.
Dr. David Altshuler, chief scientific officer, Vertex Pharmaceuticals
Permission granted by Vertex
Months after winning the first-ever approval of a CRISPR-based gene-editing therapy, the compa…
